Vitamin D, K and Hypertension

vitamin d k letter fb

The combination of low vitamin D and K status was associated with increased blood pressure and a trend for greater hypertension risk new research published in the journal, Hypertension, reports.

Studying a cohort from the Longitudinal Ageing Study Amsterdam (LASA) (n = 231) which began in 2002-2003, results showed that both systolic and diastolic blood pressures were highest in the low vitamin D and low vitamin K (dephosphorylated uncarboxylated matrix gla protein) status group. During follow up which took place in three cycles – 2005-06, 2008-09, and 2011-12 - the average increase in systolic and diastolic blood pressure was 7.4±17.3 and 2.5±9.7.

"In the current study, we reported associations of serum 25(OH)D (vitamin D) and dp-ucMGP (vitamin K) with blood pressure and incident hypertension in a population-based cohort with serial follow-up in older men and women. The combination of low vitamin D (<50 nmol/L) and low vitamin K (≥323 pmol/L) status was associated with increased systolic and diastolic blood pressure, with a similar trend for incident hypertension, albeit not statistically significant," the researchers reported.

"To our knowledge, the importance of optimal vitamin D and K concentrations on blood pressure and incident hypertension has thus far only been studied in isolation. Previous prospective studies have reported lower plasma vitamin D concentrations to be associated with higher hypertension risk and higher dp-ucMGP concentrations to be associated with arterial stiffness and a higher risk of coronary artery calcification."

The authors suggest the potential mechanism to explain the joint association of vitamin D and K is via stimulation of the γ-carboxylase system of vitamin K–dependent proteins as two of these proteins are Gla-containing proteins - osteocalcin and MGP- which play a role in the development of coronary artery disease.

"Osteocalcin has been shown to have a regulatory role in bone mineralization and calcium ion homeostasis with the potential to prevent calcium build-up in soft tissues, thereby, preventing vascular calcification and MGP limits calcium incorporation into the extracellular matrix of soft tissues, thus, acting as a potent inhibitor of soft tissue calcification," the authors explained.

"Activation of osteocalcin and MGP is dependent on vitamin K, which acts as a cofactor in the carboxylation cycle. Low expression or inactivation of vitamin K–dependent proteins can lead to vascular stiffness, which can increase blood pressure and incident hypertension risk. Circulating vitamin D has been shown to increase MGP mRNA expression in humans."

As the first study investigating joint associations of vitamin D and vitamin K in relation to cardiovascular health, the authors concluded that further prospective studies are needed to better understand the clinical implications of this relationship to promote cardiovascular health.

Some of our Brands

balancebanabanblackmoresbraggcabotherbsofgoldneoflamthompsons

Testimonials

  •  Rachael W

    ★★★★★
    Wonderful customer service :)
    -- via facebook

  • 1
  • 2
  • 3
  • 4

Contacts

  This email address is being protected from spambots. You need JavaScript enabled to view it.
  07 4681 1575
  07 3053 8308
  Shop 1/10 Davadi St, Stanthorpe